OTC Zantac name recognition will help overcome late market entry, consultant predicts.
This article was originally published in The Tan Sheet
Executive Summary
OTC ZANTAC NAME RECOGNITION WILL HELP OVERCOME LATE MARKET ENTRY, KLINE & CO. Healthcare Practice Manager Kathryn Greengrove Griffie predicted at a May 17 session of an Rx-to-OTC switch conference sponsored by International Business Communications in Washington, D.C. Griffie prophesied that sales of an OTC version of Glaxo Wellcome's Zantac H2-antagonist "will be significant" because "brand recognition for Zantac is huge."